+38 063 723 45 66 Monday-Friday 10:00-17:00
Item added
Cart
  • Your shopping cart is empty
Total 0₴

MODAWAKE – potency remedy | Buy in Ukraine with delivery

Sort By:
MODAWAKE 200
MODAWAKE 200
Modafinil 200 mg
Number of tablets
300

What is MODAWAKE?

MODAWAKE is a modern medication belonging to the pharmacological group of psychostimulants and nootropic agents with a pronounced wakefulness-promoting effect. The primary purpose of the drug is to increase alertness, improve cognitive functions, and eliminate excessive daytime sleepiness in patients with relevant disorders. The medication is available in the form of oral tablets, ensuring ease of administration and accurate dosing. MODAWAKE is manufactured in compliance with international Good Manufacturing Practice quality standards, guaranteeing the stability of the pharmacological properties of each batch. Thanks to its balanced composition, the drug demonstrates a predictable therapeutic profile and is well-tolerated by most patients.

The mechanism of action of MODAWAKE is based on its influence on neurotransmitter systems in the brain, particularly the metabolism of dopamine, norepinephrine, and histamine in structures responsible for regulating the sleep-wake cycle. Unlike classic amphetamine-based psychostimulants, the drug does not cause pronounced euphoria, sharp fluctuations in blood pressure, or significant psychomotor agitation. This action profile allows MODAWAKE to be used in clinical practice for long-term therapy without a substantial risk of developing dependence. The drug is well-absorbed in the gastrointestinal tract, reaching peak plasma concentration two to three hours after ingestion. The therapeutic effect persists for twelve to fifteen hours, allowing once-daily administration.

MODAWAKE is a prescription medication, which means its use is only possible after consulting a doctor and obtaining an accurate diagnosis. Self-medication with this drug is unacceptable, as improper dosage selection or ignoring contraindications can lead to adverse health consequences. The doctor evaluates the individual characteristics of the patient, the presence of concomitant diseases, and potential risks before prescribing MODAWAKE. The drug has proven to be an effective agent in the comprehensive treatment of sleep and wakefulness disorders, as well as in cases requiring the maintenance of a high level of concentration. It is important to remember that every organism reacts to medications individually; therefore, the efficacy and tolerability of MODAWAKE may vary among different patients.

What is MODAWAKE prescribed for?

The main indication for the use of MODAWAKE is narcolepsy — a chronic neurological disorder characterized by uncontrollable daytime sleep attacks and sudden loss of muscle tone. The medication helps patients with this diagnosis maintain an adequate level of alertness during the active part of the day, reducing the frequency and intensity of daytime sleepiness episodes. Thanks to a stable therapeutic effect, patients with narcolepsy can return to a full social life, professional activities, and driving under medical supervision. MODAWAKE significantly improves the quality of life of individuals suffering from this pathology, reducing the risk of dangerous situations associated with sudden sleep onset.

The second important indication is obstructive sleep apnea syndrome, in which patients experience repeated pauses in breathing during sleep, leading to chronic sleep deprivation and severe daytime sleepiness. MODAWAKE is prescribed as an adjunctive therapy to the primary treatment, which includes the use of continuous positive airway pressure devices. The drug helps overcome residual sleepiness in patients who adhere to all apnea treatment recommendations but still struggle to maintain daytime alertness. This approach allows for a comprehensive impact on the problem, combining mechanical airway correction with pharmacological support of the central nervous system.

MODAWAKE is also used for shift work sleep disorder, when a person's professional activity involves an non-standard sleep and wakefulness schedule, leading to chronic desynchronization of biological rhythms. In such cases, the drug helps adapt the body to the need to remain vigilant during night hours or during rapid time zone changes. Furthermore, in certain clinical situations, a doctor may prescribe MODAWAKE for pronounced daytime sleepiness associated with depressive states or other neurological disorders; however, such use requires special caution. The decision to prescribe the drug is always made individually, taking into account the complete clinical picture.

Composition and active ingredients of MODAWAKE

The active substance in MODAWAKE is modafinil — a synthetic compound belonging to the class of benzhydrylsulfinylacetamides that exhibits a unique spectrum of pharmacological activity. Modafinil acts primarily at the level of the hypothalamus, where the sleep-wake cycle regulation centers are located, increasing the release of excitatory neurotransmitters. Unlike traditional stimulants, modafinil does not cause generalized excitation of the entire nervous system, but selectively activates those brain regions responsible for maintaining a state of wakefulness. This mechanism provides a mild but sustained stimulating effect without feelings of anxiety, tremors, or excessive motor activity characteristic of other psychostimulants.

The excipients in MODAWAKE act as stabilizers, fillers, and agents ensuring the proper pharmacokinetic properties of the tablet form. These include lactose, microcrystalline cellulose, starch, povidone, and magnesium stearate, which guarantee uniform distribution of the active substance in each tablet. Due to the balanced composition of excipients, the drug has a stable dissolution rate and predictable bioavailability regardless of food intake. MODAWAKE is produced in two dosages — 100 mg and 200 mg of modafinil — allowing the physician flexibility in choosing the optimal therapeutic dose for each patient.

The pharmacological action of modafinil is realized through a complex cascade of neurochemical processes, among which a key role is played by the inhibition of dopamine reuptake and an increase in its extracellular concentration in the prefrontal cortex. In addition, the drug affects the histaminergic system by stimulating the release of histamine in the hypothalamus, which enhances alertness. An important feature of MODAWAKE is the absence of a significant effect on the peripheral nervous system, due to which the drug does not cause a pronounced increase in blood pressure or heart rate. This action profile makes modafinil the drug of choice for patients requiring long-term pharmacological wakefulness support without significant cardiovascular risks.

Dosage of MODAWAKE

The standard recommended dose of MODAWAKE for adult patients is 200 mg once daily, preferably taken in the morning or one hour prior to the start of a work shift in the case of shift work. For elderly patients or individuals with impaired liver function, the doctor may initiate therapy at a lower dose — 100 mg daily — followed by adjustment depending on the clinical response. The maximum daily dose should not exceed 400 mg; however, such a dosage is used only in exceptional cases under strict medical supervision. The duration of the treatment course is determined individually depending on the diagnosis, severity of symptoms, and therapeutic efficacy.

In narcolepsy, MODAWAKE is usually prescribed for a long term, as the disease is chronic and requires continuous maintenance therapy. Patients with obstructive sleep apnea syndrome are recommended to take the medication daily in the morning without discontinuing the primary equipment used to maintain airway patency. In the case of shift work sleep disorder, MODAWAKE is taken one hour before the start of the night shift, allowing optimal vigilance levels to be maintained throughout working hours. The physician may adjust the dose based on the patient's individual sensitivity and the severity of side effects.

Patients with severe renal impairment are recommended a dose reduction of MODAWAKE due to slowed elimination of the drug from the body. Elderly individuals should begin treatment with the minimum effective dose, as age-related metabolic changes can increase sensitivity to the active component. If the therapeutic response to the initial dose is insufficient, the doctor may gradually increase it at intervals of no less than one week. Adjusting the dosage or frequency of MODAWAKE independently without consulting a doctor is strictly prohibited, as this can lead to the development of serious adverse reactions.

How to take MODAWAKE correctly?

MODAWAKE is taken orally, swallowing the tablet with a sufficient amount of water, regardless of meal times; however, it should be noted that consuming fatty food may delay the absorption of the drug and postpone the onset of its therapeutic effect. To achieve maximum efficacy, it is recommended to take the drug at the same time every day, which helps maintain a stable concentration of the active substance in the blood. Because MODAWAKE has a strong wakefulness-promoting effect, it should not be taken in the afternoon or before bed, as this may cause insomnia and disruption of circadian rhythms. The optimal time for intake is in the morning after waking up or one hour before starting a night shift for shift workers.

If a dose of MODAWAKE is missed, the patient should take it as soon as possible if there are more than six hours left until the next scheduled dose. If the missed dose is discovered closer to the evening, it is better to skip the forgotten dose and return to the normal schedule the following morning to avoid disrupting night sleep. Doubling the dose to compensate for a missed one is not recommended, as this increases the risk of side effects without providing additional therapeutic benefit. Patients must maintain a regular sleep and rest schedule during treatment with MODAWAKE, as the drug does not replace full sleep, but only helps maintain alertness when needed.

During MODAWAKE therapy, it is important to undergo regular medical examinations to monitor blood pressure, heart rate, and the general state of the cardiovascular system. The drug can reduce the effectiveness of hormonal contraceptives; therefore, women of reproductive age should use additional or alternative contraceptive methods throughout the entire treatment period and for two months after its completion. Patients taking MODAWAKE should exercise caution when driving vehicles or performing tasks requiring increased concentration until their individual response to the medication has been established. The occurrence of any unusual symptoms or deterioration of well-being is a reason for immediate consultation with a doctor.

Side effects of MODAWAKE

The most common side effects of MODAWAKE, observed in more than five percent of patients, are headache, nausea, decreased appetite, anxiety, and insomnia. Headaches usually occur at the beginning of therapy and tend to diminish after the first few weeks of intake; however, if significant in intensity, dose adjustment may be required. Decreased appetite is an expected effect related to the drug's impact on hunger regulation centers in the hypothalamus, so patients are advised to monitor their body weight and ensure adequate nutrient intake. Insomnia occurs primarily when the intake regimen is violated, particularly when taking the medication in the afternoon.

Less common adverse reactions to MODAWAKE include tachycardia, palpitations, increased blood pressure, dizziness, dry mouth, and gastrointestinal disturbances. Some patients may experience mood changes, irritability, emotional lability, or depressive manifestations, which require medical attention and potential adjustment of therapy. Rare but serious side effects include allergic reactions, including skin rash, urticaria, angioedema, and in isolated cases, severe cutaneous reactions such as Stevens-Johnson syndrome. The appearance of any skin rashes, facial swelling, or difficulty breathing requires immediate discontinuation of the drug and prompt medical assistance.

Patients should be informed of the potential development of psychiatric side effects, including hallucinations, manic states, or worsening of anxiety disorders, especially in those with a history of psychiatric illness. If such symptoms occur, a doctor should be consulted immediately to evaluate the appropriateness of continuing MODAWAKE therapy. It is important to remember that an individual's reaction to the drug can vary significantly; therefore, the listed side effects are not exhaustive. Regular medical monitoring during treatment allows for the timely detection of adverse events and the implementation of appropriate measures to eliminate them.

Contraindications of MODAWAKE

MODAWAKE has several absolute contraindications, in the presence of which the use of the drug is strictly prohibited. These include hypersensitivity to modafinil or any excipient, which may manifest as allergic reactions of varying severity. The drug is not prescribed to patients with uncontrolled arterial hypertension, severe cardiac arrhythmias, or to individuals who have suffered a myocardial infarction or unstable angina within the last three months. The presence of hypertrophic cardiomyopathy or mitral valve prolapse with marked regurgitation is also a contraindication to the use of MODAWAKE due to potential effects on the cardiovascular system.

Special caution is required when prescribing MODAWAKE to patients with psychiatric disorders, particularly psychoses, bipolar disorder, or severe depression, as the drug can trigger an exacerbation of symptoms. For pregnant women, MODAWAKE is prescribed only in cases where the expected benefit to the mother outweighs the potential risk to the fetus, as safety data during this period are limited. Women of childbearing potential are recommended to use reliable contraceptive methods during therapy and for two months following its completion. Breastfeeding is a contraindication for taking MODAWAKE, as the active substance penetrates into breast milk and may affect the infant.

The medication is not used in pediatric practice due to a lack of sufficient safety and efficacy data in children under eighteen years of age. For elderly patients, MODAWAKE is prescribed with caution and at reduced doses due to an increased risk of side effects and the presence of concomitant diseases. Individuals with severe hepatic impairment are recommended to halve the dose, since the metabolism of the drug occurs primarily in the liver. Prior to starting MODAWAKE therapy, the patient must undergo a complete medical examination to rule out hidden contraindications and assess overall health.

Interaction of MODAWAKE with other drugs and alcohol

MODAWAKE can interact with a number of medications, requiring mandatory disclosure to the doctor of all drugs the patient is taking on a regular basis. Modafinil is an inducer of cytochrome P450 enzymes, specifically the CYP3A4 isoenzyme, so it can accelerate the metabolism of hormonal contraceptives, anticoagulants, certain antidepressants, and antiepileptic agents, reducing their efficacy. Concomitant use of MODAWAKE with monoamine oxidase inhibitors, tricyclic antidepressants, or selective serotonin reuptake inhibitors requires special caution due to the risk of developing serotonin syndrome. Patients taking warfarin or other anticoagulants require regular monitoring of blood clotting parameters throughout the period of MODAWAKE therapy.

Alcohol consumption during MODAWAKE treatment is not recommended, as ethanol can enhance the drug's side effects on the central nervous system and increase the risk of unpredictable reactions. Alcohol is capable of masking or distorting the therapeutic effect of modafinil, complicating the assessment of dose adequacy and potentially leading to an erroneous dosage increase. Furthermore, combining MODAWAKE with alcohol places an extra burden on the liver, which is involved in the metabolism of both substances. Patients should refrain from driving vehicles and operating machinery until their individual reaction to the drug is established, especially at the start of therapy or after a dose change.

Where to buy MODAWAKE in Ukraine

MODAWAKE is a prescription medication, so its purchase is possible only with a valid prescription from a doctor in pharmacy establishments licensed to sell pharmaceutical products. The drug is available in many pharmacy chains in major Ukrainian cities, as well as in specialized online pharmacies that deliver upon prescription verification. Patients are advised to contact verified pharmacy institutions that guarantee proper storage conditions and authenticity of the medication. The cost of MODAWAKE may vary depending on the dosage, the number of tablets in the package, and the pricing policy of the specific pharmacy.

MODAWAKE must be stored in its original packaging at a temperature not exceeding twenty-five degrees Celsius, in a dry place protected from direct sunlight, out of the reach of children. The shelf life of the drug is usually three years from the date of manufacture, after which use is strictly prohibited. Before purchasing MODAWAKE, the patient should ensure they have a valid prescription and consult with a doctor regarding the correctness of the chosen dose. Self-medication and purchasing the drug without a medical prescription are unacceptable and may pose a risk to the patient's health.

Free delivery from UAH 1000

Across Ukraine

Featured

Order with delivery

Self-medication can be dangerous to your health. Consult a doctor before using this medication..